Approvals

Exclusive news, data and analytics for financial market professionals

Skip to main content

Approvals

36 results

Future of HealthcategoryU.S. FDA approves GSK's anemia drug for patients on dialysis, article with imageFebruary 2, 2023
BusinesscategoryU.S. FDA removes COVID test requirements for Pfizer, Merck pills, article with galleryFebruary 1, 2023
WorldcategoryU.S. food safety regulator announces shakeup after infant formula crisis, article with imageJanuary 31, 2023
BusinesscategoryFDA classifies recall of LivaNova's blood-pumping system controller as most serious, article with imageJanuary 27, 2023
WorldcategoryU.S. FDA proposes to ease sexual abstinence rule for blood donors, article with imageJanuary 27, 2023
BusinesscategoryFDA identifies recall of Emergent's decontamination kits as most serious, article with imageJanuary 26, 2023
BusinesscategoryU.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld, article with imageJanuary 26, 2023
Future of HealthcategoryU.S. FDA calls for new regulatory framework for use of cannabis compound CBD, article with galleryJanuary 26, 2023
BusinesscategoryFDA classifies recall of Getinge's heart devices as most serious, article with galleryJanuary 26, 2023
BusinesscategoryU.S. FDA joins global regulators probing tainted overseas cough syrup, article with galleryJanuary 25, 2023
WorldcategoryU.S. FDA proposes limits on lead in processed baby food, article with imageJanuary 24, 2023
United StatescategoryU.S. FDA proposes shift to annual COVID vaccine shots, article with videoJanuary 23, 2023
Healthcare & PharmaceuticalscategoryEli Lilly says U.S. FDA rejects accelerated approval for Alzheimer's drug, article with galleryJanuary 20, 2023
BusinesscategoryFDA warns Japan's Olympus units over testing violations, article with imageJanuary 10, 2023
BusinesscategoryU.S. FDA panel to review Emergent's OTC opioid overdose drug, article with imageJanuary 10, 2023
Future of HealthcategoryEisai, Biogen get U.S. FDA approval for Alzheimer's drug, apply for full approval, article with galleryJanuary 7, 2023
BusinesscategoryEisai files for full FDA approval for Alzheimer's drug Leqembi, article with imageJanuary 7, 2023
BusinesscategoryFactbox: Who can get the newly approved Eisai and Biogen Alzheimer's drug?, article with imageJanuary 6, 2023
BusinesscategoryU.S. FDA says Evusheld may not protect against Omicron subvariant XBB.1.5, article with imageJanuary 6, 2023
WorldcategoryWalgreens, CVS plan to start offering abortion pills, article with imageJanuary 5, 2023

1 to 20 of 36